跳至主要内容
临床试验/RPCEC00000440
RPCEC00000440尚未招募Unknown

Study of the efficacy, safety and tolerability of soft capsules with ozonated sunflower oil versus oral OLEOZON® in patients with Giardiosis - AGO-GIA

ational Centre for Scientific Research (CNIC)0 个研究点目标入组 200 人开始时间: 2024年5月9日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled trial. Masking: Open. Control group: Active. Assignment: Parallel. Purpose: Treatment

入排标准

年龄范围
19 years 至 one(—)
性别
All

入选标准

  • Patients of both sexes, with 19 years or older, with gastrointestinal symptoms as diarrhea, pain in the upper abdomen, nausea, vomiting, weight loss, bloating or hivesand, a confirmatory diagnosis of Giardiosis who attend an outpatient clinic at the Institute of Gastroenterology and agree to participate in the study, written informed consent.

排除标准

  • Patients with:
  • 1. Other parasites
  • 3. Decompensated chronic diseases
  • 4. Diagnosed neoplasms
  • 5. Pregnant or lactating women
  • 6. Hypersensitivity to the study drug

研究者

发起方
ational Centre for Scientific Research (CNIC)

相似试验